APA (7th ed.) Citation

NG, R., V, G., CML, L., HS, M., B, G., JN, K., & B, M. (2024). Novel biomarker SARIFA in colorectal cancer: Highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology. Cancer gene therapy, 31(2), 207. https://doi.org/10.1038/s41417-023-00695-y

Chicago Style (17th ed.) Citation

NG, Reitsam, Grozdanov V, Löffler CML, Muti HS, Grosser B, Kather JN, and Märkl B. "Novel Biomarker SARIFA in Colorectal Cancer: Highly Prognostic, Not Genetically Driven and Histologic Indicator of a Distinct Tumor Biology." Cancer Gene Therapy 31, no. 2 (2024): 207. https://doi.org/10.1038/s41417-023-00695-y.

MLA (9th ed.) Citation

NG, Reitsam, et al. "Novel Biomarker SARIFA in Colorectal Cancer: Highly Prognostic, Not Genetically Driven and Histologic Indicator of a Distinct Tumor Biology." Cancer Gene Therapy, vol. 31, no. 2, 2024, p. 207, https://doi.org/10.1038/s41417-023-00695-y.